About
Novel therapies for serotonergic driven disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
1
As Collaborator
5
Total Enrollment
580
By Phase
PHASE4: 1NA: 1
By Status
COMPLETED: 4RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT04703166Collaborator
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
N/ARecruiting
360 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2027
NCT04704050Collaborator
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
PHASE4Terminated
22 participants
Started: May 15, 2021 · Completed: Dec 20, 2022
NCT02391987Collaborator
Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure
NACompleted
112 participants
Started: May 31, 2015 · Completed: Mar 31, 2019
NCT02255526Lead Sponsor
BodyGuardian Respiration and Activity Validation Testing
N/ACompleted
24 participants
Started: Sep 30, 2014 · Completed: Jul 31, 2016
NCT01975402Collaborator
Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population
N/ACompleted
42 participants
Started: Nov 30, 2013 · Completed: Mar 31, 2019
Locations (1)
Headquarters
Exton, PA, United States
Map
Loading map...